Skip to main content
Erschienen in: Current Oncology Reports 9/2015

01.09.2015 | Integrative Care (C Lammersfeld, Section Editor)

Is There a Role for Homeopathy in Cancer Care? Questions and Challenges

verfasst von: Moshe Frenkel

Erschienen in: Current Oncology Reports | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Patients with cancer commonly use complementary and integrative medicine, including homeopathy. Homeopathy has grown in popularity with the public but is viewed with skepticism by medical academia and is still excluded from conventionally prescribed treatments. In recent years, homeopathy has been used in cancer care in Europe and other countries worldwide. This use raised the question if there is any benefit in utilizing this type of care with cancer patients. The purpose of this manuscript is to explore the evidence related to the benefit of homeopathy in cancer care. Limited research has suggested that homeopathic remedies appear to cause cellular changes in some cancer cells. In animal models, several homeopathic remedies have had an inhibitory effect on certain tumor development. Some clinical studies of homeopathic remedies combined with conventional care have shown that homeopathic remedies improve quality of life, reduce symptom burden, and possibly improve survival in patients with cancer. The findings from several lab and clinical studies suggest that homeopathy might have some beneficial effect in cancer care; however, further large, comprehensive clinical studies are needed to determine these beneficial effects. Although additional studies are needed to confirm these findings, given the low cost, minimal risks, and the potential magnitude of homeopathy’s effects, this use might be considered in certain situations as an additional tool to integrate into cancer care.
Literatur
1.
Zurück zum Zitat Mao JJ, Cohen L. Advancing the science of integrative oncology to inform patient-centered care for cancer survivors. J Natl Cancer Inst Monogr. 2014;50:283–4.CrossRef Mao JJ, Cohen L. Advancing the science of integrative oncology to inform patient-centered care for cancer survivors. J Natl Cancer Inst Monogr. 2014;50:283–4.CrossRef
2.
Zurück zum Zitat Rowland JH, O’Mara A. Survivorship care planning: unique opportunity to champion integrative oncology. J Natl Cancer Inst Monogr. 2014;50:285.CrossRef Rowland JH, O’Mara A. Survivorship care planning: unique opportunity to champion integrative oncology. J Natl Cancer Inst Monogr. 2014;50:285.CrossRef
3.
Zurück zum Zitat Briggs J. Building the evidence base for integrative approaches to care of cancer survivors. J Natl Cancer Inst Monogr. 2014;50:288.CrossRef Briggs J. Building the evidence base for integrative approaches to care of cancer survivors. J Natl Cancer Inst Monogr. 2014;50:288.CrossRef
4.
Zurück zum Zitat Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults: United States, 2002–2012. National health statistics reports, no. 79. Hyattsville, MD: National Center for Health Statistics, 2015. Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults: United States, 2002–2012. National health statistics reports, no. 79. Hyattsville, MD: National Center for Health Statistics, 2015.
6.
Zurück zum Zitat Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655–3.PubMedCrossRef Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655–3.PubMedCrossRef
7.
Zurück zum Zitat Downer SM, Cody MM, McCluskey P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309(6947):86–9.PubMedCentralPubMedCrossRef Downer SM, Cody MM, McCluskey P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309(6947):86–9.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Trager-Maury S, Tournigand C, Maindrault-Goebel F, et al. Use of complementary medicine by cancer patients in a French oncology department. Bull Cancer. 2007;94:1017–25.PubMed Trager-Maury S, Tournigand C, Maindrault-Goebel F, et al. Use of complementary medicine by cancer patients in a French oncology department. Bull Cancer. 2007;94:1017–25.PubMed
9.
Zurück zum Zitat Längler A, Spix C, Edelhäuser F, Kameda G, Kaatsch P, Seifert G. Use of homeopathy in pediatric oncology in Germany. Evid Based Complement Alternat Med. 2011;2011:867151.PubMedCentralPubMedCrossRef Längler A, Spix C, Edelhäuser F, Kameda G, Kaatsch P, Seifert G. Use of homeopathy in pediatric oncology in Germany. Evid Based Complement Alternat Med. 2011;2011:867151.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Koehl B, Muenstedt K, Micke O, et al. Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat. 2014;37(1–2):49–53.PubMedCrossRef Koehl B, Muenstedt K, Micke O, et al. Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat. 2014;37(1–2):49–53.PubMedCrossRef
11.
Zurück zum Zitat Bonacchi A, Fazzi L, Toccafondi A, et al. Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy. J Pain Symptom Manage. 2014;47(1):26–34.PubMedCrossRef Bonacchi A, Fazzi L, Toccafondi A, et al. Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy. J Pain Symptom Manage. 2014;47(1):26–34.PubMedCrossRef
12.
Zurück zum Zitat Johannessen H, von Bornemann Hjelmborg J, Pasquarelli E, et al. Prevalence in the use of complementary medicine among cancer patients in Tuscany, Italy. Tumori. 2008;94:406–10.PubMed Johannessen H, von Bornemann Hjelmborg J, Pasquarelli E, et al. Prevalence in the use of complementary medicine among cancer patients in Tuscany, Italy. Tumori. 2008;94:406–10.PubMed
13.••
Zurück zum Zitat Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centers in Europe. Support Care Cancer. 2015;23(6):1795–806. This study reveals that among 236 European centers that provide integrative oncology services in the public health system, homeopathy was one of the leading CIM therapies. PubMedCrossRef Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centers in Europe. Support Care Cancer. 2015;23(6):1795–806. This study reveals that among 236 European centers that provide integrative oncology services in the public health system, homeopathy was one of the leading CIM therapies. PubMedCrossRef
14.
Zurück zum Zitat National Health and Medical Research Council. NHMRC Information Paper: evidence on the effectiveness of homeopathy for treating health conditions. Canberra: National Health and Medical Research Council; 2015. National Health and Medical Research Council. NHMRC Information Paper: evidence on the effectiveness of homeopathy for treating health conditions. Canberra: National Health and Medical Research Council; 2015.
15.
Zurück zum Zitat Bornhoft G, Matthiessen PF. Homeopathy in healthcare: effectiveness, appropriateness, safety, costs. Goslar: Springer; 2011.CrossRef Bornhoft G, Matthiessen PF. Homeopathy in healthcare: effectiveness, appropriateness, safety, costs. Goslar: Springer; 2011.CrossRef
17.
Zurück zum Zitat Olaku O, Zia F, Santana JM, White JD. The National Cancer Institute Best Case Series Program: a summary of cases of cancer patients treated with unconventional therapies in India. Integr Cancer Ther. 2013;12(5):385–92.PubMedCrossRef Olaku O, Zia F, Santana JM, White JD. The National Cancer Institute Best Case Series Program: a summary of cases of cancer patients treated with unconventional therapies in India. Integr Cancer Ther. 2013;12(5):385–92.PubMedCrossRef
19.
Zurück zum Zitat Banerji P, Campbell DR, Banerji P. Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA. Oncol Rep. 2008;20:69–74.PubMed Banerji P, Campbell DR, Banerji P. Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA. Oncol Rep. 2008;20:69–74.PubMed
20.
Zurück zum Zitat Pathak S, Multani AS, Banerji P, Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol. 2003;23:975–82.PubMed Pathak S, Multani AS, Banerji P, Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol. 2003;23:975–82.PubMed
21.
Zurück zum Zitat Witt CM, Ludtke R, Mengler N, Willich SN. How healthy are chronically ill patients after eight years of homeopathic treatment? Results from a long-term observational study. BMC Public Health. 2008;8:413.PubMedCentralPubMedCrossRef Witt CM, Ludtke R, Mengler N, Willich SN. How healthy are chronically ill patients after eight years of homeopathic treatment? Results from a long-term observational study. BMC Public Health. 2008;8:413.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Kassab S, Cummings M, Berkovitz S, van Haselen R, Fisher P. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev. 2009;2, CD004845.PubMed Kassab S, Cummings M, Berkovitz S, van Haselen R, Fisher P. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev. 2009;2, CD004845.PubMed
23.••
Zurück zum Zitat Rostock M, Naumann J, Guethlin C, Guenther L, Bartsch HH, Walach H. Classical homeopathy in the treatment of cancer patients—a prospective observational study of two independent cohorts. BMC Cancer. 2011;11:19. In this study, researchers observed that there was an improvement in quality of life as well as improvement of fatigue symptoms in cancer patients that received homeopathic treatment in addition to conventional care as compared to patients receiving only conventional treatments. PubMedCentralPubMedCrossRef Rostock M, Naumann J, Guethlin C, Guenther L, Bartsch HH, Walach H. Classical homeopathy in the treatment of cancer patients—a prospective observational study of two independent cohorts. BMC Cancer. 2011;11:19. In this study, researchers observed that there was an improvement in quality of life as well as improvement of fatigue symptoms in cancer patients that received homeopathic treatment in addition to conventional care as compared to patients receiving only conventional treatments. PubMedCentralPubMedCrossRef
24.••
Zurück zum Zitat Frass M, Friehs H, Thallinger C, et al. Influence of adjunctive classical homeopathy on global health status and subjective well-being in cancer patients—a pragmatic randomized controlled trial. Complement Ther Med. 2015;23(3):309–17. This study evaluated the value of adding classical homeopathy to conventional cancer care in a randomized controlled trial. The study revealed a significant improvement in global health status and subjective well-being in those patients that received the homeopathic treatment compared those that did not. PubMedCrossRef Frass M, Friehs H, Thallinger C, et al. Influence of adjunctive classical homeopathy on global health status and subjective well-being in cancer patients—a pragmatic randomized controlled trial. Complement Ther Med. 2015;23(3):309–17. This study evaluated the value of adding classical homeopathy to conventional cancer care in a randomized controlled trial. The study revealed a significant improvement in global health status and subjective well-being in those patients that received the homeopathic treatment compared those that did not. PubMedCrossRef
25.
Zurück zum Zitat Jacobs J, Herman P, Heron K, Olsen S, Vaughters L. Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial. J Altern Complement Med. 2005;11:21–7.PubMedCrossRef Jacobs J, Herman P, Heron K, Olsen S, Vaughters L. Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial. J Altern Complement Med. 2005;11:21–7.PubMedCrossRef
26.••
Zurück zum Zitat Gaertner K, Müllner M, Friehs H, et al. Additive homeopathy in cancer patients: retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med. 2014;22(2):320–32. In this study, researchers collected survival data on patients with fatal disease and poor prognosis that used homeopathy in addition to conventional cancer care. The researchers found that patients that combined homeopathy in their care had prolonged survival than the expected prognosis, across all the observed cancer entities. PubMedCrossRef Gaertner K, Müllner M, Friehs H, et al. Additive homeopathy in cancer patients: retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med. 2014;22(2):320–32. In this study, researchers collected survival data on patients with fatal disease and poor prognosis that used homeopathy in addition to conventional cancer care. The researchers found that patients that combined homeopathy in their care had prolonged survival than the expected prognosis, across all the observed cancer entities. PubMedCrossRef
27.
Zurück zum Zitat Frenkel M, Cohen L, Peterson N, Swint K, Palmer L, Bruera E. Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther. 2010;9(3):276–83.PubMedCrossRef Frenkel M, Cohen L, Peterson N, Swint K, Palmer L, Bruera E. Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther. 2010;9(3):276–83.PubMedCrossRef
28.
Zurück zum Zitat Frenkel M, Mishra BM, Sen S, et al. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol. 2010;36(2):395–403.PubMed Frenkel M, Mishra BM, Sen S, et al. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol. 2010;36(2):395–403.PubMed
29.
Zurück zum Zitat Amri H, Anderson N, MacLaughlin WB, Esquivel S, Ives J, Jonas W. Effects of ultra-low dilutions of Sabal serrulata on human prostate cancer growth: mechanistic studies. Alternat Ther. 2009;15:S79–80. Amri H, Anderson N, MacLaughlin WB, Esquivel S, Ives J, Jonas W. Effects of ultra-low dilutions of Sabal serrulata on human prostate cancer growth: mechanistic studies. Alternat Ther. 2009;15:S79–80.
30.
Zurück zum Zitat MacLaughlin BW, Gutsmuths B, Pretner E, et al. Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models. Integr Cancer Ther. 2006;5:362–72.PubMedCrossRef MacLaughlin BW, Gutsmuths B, Pretner E, et al. Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models. Integr Cancer Ther. 2006;5:362–72.PubMedCrossRef
31.
Zurück zum Zitat Kumar KB, Sunila ES, Kuttan G, Preethi KC, Venugopal CN, Kuttan R. Inhibition of chemically induced carcinogenesis by drugs used in homeopathic medicine. Asian Pac J Cancer Prev. 2007;8:98–102.PubMed Kumar KB, Sunila ES, Kuttan G, Preethi KC, Venugopal CN, Kuttan R. Inhibition of chemically induced carcinogenesis by drugs used in homeopathic medicine. Asian Pac J Cancer Prev. 2007;8:98–102.PubMed
32.
Zurück zum Zitat Arora S, Aggarwal A, Singla P, Jyoti S, Tandon S. Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells. Homeopathy. 2013;102(4):274–82.PubMedCrossRef Arora S, Aggarwal A, Singla P, Jyoti S, Tandon S. Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells. Homeopathy. 2013;102(4):274–82.PubMedCrossRef
33.
Zurück zum Zitat Sunila ES, Kuttan G. A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol Immunotoxicol. 2006;28:269–80.PubMedCrossRef Sunila ES, Kuttan G. A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol Immunotoxicol. 2006;28:269–80.PubMedCrossRef
Metadaten
Titel
Is There a Role for Homeopathy in Cancer Care? Questions and Challenges
verfasst von
Moshe Frenkel
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Current Oncology Reports / Ausgabe 9/2015
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-015-0467-8

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.